Six double-blind, randomized, placebo-controlled trials were carried out with the aim of examining possible side effects that are frequently linked to the use of human growth hormone
It is not recommended for children unless prescribed by a doctor
Industries that tend to have more generous benefits (pharma, technology, finance, regulated utilities) are more likely to offer coverage for GLP-1s, over industries with higher employee turnover like retail and hospitality
Interventions: Cagrilintide, placebo Primary Outcome Measures: Relative change in body weight
A kernel density plot confirmed a normal distribution, justifying the use of parametric tests for these datasets
different molecules are likely working in synergy to elicit a specific hormonal response